Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

The company added that the device will be indicated for both paroxysmal and persistent atrial fibrillation. Citing data from its PULSED AF study, Medtronic (MDT) said that the PulseSelect PFA ...

The FDA recently announced critical recalls on several widely used medical devices, including Life2000 ventilators, Medtronic's MiniMed insulin pumps and Boston Scientific's Obsidio conformable ...

The Centers for Medicare & Medicaid Services granted transitional pass-through (TPT) payment status to Medtronic and Recor Medical for renal denervation devices to treat high blood pressure.

Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...

Medtronic and Recor Medical, Inc. (and its parent company, Otsuka Medical Devices Co., Ltd.) separately and independently ...

2024 (and announced by FDA on October 17), the company issued an “Urgent Medical Device Correction” letter, advising users to do the following: From January 2023 to September 2024, Medtronic ...

The three medtech firms unveiled new data this week during TCT 2024 in Washington, D.C. Here’s what the results mean for the ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

Medtronic announced today that it appointed Dr. Matthew Kroh as chief medical officer for Advanced and General Surgical Technologies.

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves ...